vs
Side-by-side financial comparison of LENZ Therapeutics, Inc. (LENZ) and SuperCom Ltd (SPCB). Click either name above to swap in a different company.
SuperCom Ltd is the larger business by last-quarter revenue ($14.2M vs $12.5M, roughly 1.1× LENZ Therapeutics, Inc.). SuperCom Ltd runs the higher net margin — 37.5% vs -133.6%, a 171.1% gap on every dollar of revenue. SuperCom Ltd produced more free cash flow last quarter ($-3.6M vs $-9.0M).
LENZ Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing novel ophthalmic therapies. Its lead product candidates address presbyopia, the age-related loss of near vision, catering to global patient groups with unmet medical needs in the eye care sector.
Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.
LENZ vs SPCB — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $14.2M |
| Net Profit | $-16.7M | $5.3M |
| Gross Margin | — | 61.2% |
| Operating Margin | -151.1% | 16.3% |
| Net Margin | -133.6% | 37.5% |
| Revenue YoY | — | -1.5% |
| Net Profit YoY | -63.5% | 79.5% |
| EPS (diluted) | $-0.59 | $1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $12.5M | — | ||
| Q2 25 | $5.0M | $14.2M | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | $14.4M | ||
| Q2 23 | — | $14.1M | ||
| Q2 22 | — | $6.3M |
| Q3 25 | $-16.7M | — | ||
| Q2 25 | $-14.9M | $5.3M | ||
| Q3 24 | $-10.2M | — | ||
| Q2 24 | $-10.3M | $3.0M | ||
| Q2 23 | — | $-2.6M | ||
| Q2 22 | — | $-5.2M |
| Q3 25 | — | — | ||
| Q2 25 | — | 61.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 52.3% | ||
| Q2 23 | — | 27.2% | ||
| Q2 22 | — | 41.8% |
| Q3 25 | -151.1% | — | ||
| Q2 25 | -337.1% | 16.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 7.7% | ||
| Q2 23 | — | -12.2% | ||
| Q2 22 | — | -49.9% |
| Q3 25 | -133.6% | — | ||
| Q2 25 | -298.2% | 37.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 20.6% | ||
| Q2 23 | — | -18.3% | ||
| Q2 22 | — | -82.4% |
| Q3 25 | $-0.59 | — | ||
| Q2 25 | $-0.53 | $1.32 | ||
| Q3 24 | $-0.38 | — | ||
| Q2 24 | $-0.40 | $1.19 | ||
| Q2 23 | — | $-10.66 | ||
| Q2 22 | — | $-1.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.4M | $15.0M |
| Total DebtLower is stronger | — | $23.6M |
| Stockholders' EquityBook value | $193.9M | $37.3M |
| Total Assets | $210.7M | $65.5M |
| Debt / EquityLower = less leverage | — | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $25.4M | — | ||
| Q2 25 | $37.6M | $15.0M | ||
| Q3 24 | $41.0M | — | ||
| Q2 24 | $84.0M | $5.7M | ||
| Q2 23 | — | $1.1M | ||
| Q2 22 | — | $2.9M |
| Q3 25 | — | — | ||
| Q2 25 | — | $23.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $29.2M | ||
| Q2 23 | — | $32.9M | ||
| Q2 22 | — | $32.3M |
| Q3 25 | $193.9M | — | ||
| Q2 25 | $206.4M | $37.3M | ||
| Q3 24 | $215.3M | — | ||
| Q2 24 | $192.9M | $13.8M | ||
| Q2 23 | — | $3.5M | ||
| Q2 22 | — | $3.7M |
| Q3 25 | $210.7M | — | ||
| Q2 25 | $217.3M | $65.5M | ||
| Q3 24 | $224.0M | — | ||
| Q2 24 | $202.6M | $49.6M | ||
| Q2 23 | — | $40.8M | ||
| Q2 22 | — | $42.7M |
| Q3 25 | — | — | ||
| Q2 25 | — | 0.63× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.11× | ||
| Q2 23 | — | 9.49× | ||
| Q2 22 | — | 8.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.6M | $-2.2M |
| Free Cash FlowOCF − Capex | $-9.0M | $-3.6M |
| FCF MarginFCF / Revenue | -72.2% | -25.3% |
| Capex IntensityCapex / Revenue | 3.5% | 10.0% |
| Cash ConversionOCF / Net Profit | — | -0.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-47.5M | $-14.0M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-8.6M | — | ||
| Q2 25 | $-11.5M | $-2.2M | ||
| Q3 24 | $-10.6M | — | ||
| Q2 24 | $-15.8M | $-950.0K | ||
| Q2 23 | — | $-3.4M | ||
| Q2 22 | — | $-4.1M |
| Q3 25 | $-9.0M | — | ||
| Q2 25 | $-11.7M | $-3.6M | ||
| Q3 24 | $-10.8M | — | ||
| Q2 24 | $-15.9M | $-1.6M | ||
| Q2 23 | — | $-4.5M | ||
| Q2 22 | — | $-4.4M |
| Q3 25 | -72.2% | — | ||
| Q2 25 | -235.0% | -25.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -10.8% | ||
| Q2 23 | — | -31.5% | ||
| Q2 22 | — | -70.4% |
| Q3 25 | 3.5% | — | ||
| Q2 25 | 4.8% | 10.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 4.2% | ||
| Q2 23 | — | 7.4% | ||
| Q2 22 | — | 4.4% |
| Q3 25 | — | — | ||
| Q2 25 | — | -0.41× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.32× | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
